Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-09-07-Speech-3-127"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2005-09-07"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20050907.15.3-127"2
lpv:hasSubsequent	lp_eu:2005-09-07-Speech-3-1282
lpv:speaker	lp:Linda McAVAN2
lpv:spoken text	". Labour MEPs support the principle of awarding incentives to pharmaceutical companies in order to stimulate the necessary research and development. We therefore support the concept of extending the SPC, but question the Commission proposal for an automatic six-month extension. We feel a variable length SPC extension would have been better and fairer, because the amount of incentive would better have reflected the costs of research. Of the options on the table, we therefore supported the three- plus three-month extension. We did not, however, support the option of a fixed four- or five- month SPC extension, because this risks being unfair to smaller companies."@en1
lpv:spokenAs	substitute; Delegation for relations with the Palestinian Legislative Council (2004-09-15--2005-09-22)3 treasurer; PES (2004-07-20--2007-02-13)3 member; ENVI (2004-07-21--2007-01-14)3 substitute; DEVE (2004-07-21--2007-01-14)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-09-15--2009-07-13)3 unknown; Labour Party (2004-07-20--2009-07-13)3
lpv:unclassifiedMetadata	"Linda McAvan (PSE ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph